Evidence map›Paper›PMID 35673545›Full record

ArticleWellcome open research2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study.

Alexandra Cann, Candice Clarke, Jonathan Brown, Tina Thomson, Maria Prendecki, Maya Moshe, Anjna Badhan, Bryony Simmons, Bob Klaber, Paul Elliott and 10 more

Open access · goldAbstract read
In one paragraph

Article in Wellcome open research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 1 country.

Alexandra Cann *Department of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-7410-8407
Candice Clarke *Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
Jonathan Brown *Department of Infectious Disease, Imperial College London, London, UK.
Tina ThomsonCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-6814-3241
Maria PrendeckiCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
Maya MosheCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-3451-3579
Anjna BadhanDepartment of Infectious Disease, Imperial College London, London, UK.
Bryony SimmonsLSE Health, London School of Economics and Political Science, London, UK.
Bob KlaberImperial College Healthcare NHS Trust, London, UK.
Paul ElliottDepartment of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0002-7511-5684
Ara DarziDepartment of Infectious Disease, Imperial College London, London, UK.
Steven RileyDepartment of Infectious Disease, Imperial College London, London, UK.
Deborah AshbyDepartment of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-3146-7466
Paul MartinCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.ORCID https://orcid.org/0000-0003-3081-848X
Sarah GleesonCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
Michelle WillicombeCentre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, London, UK.
Peter KelleherDepartment of Infectious Disease, Imperial College London, London, UK.
Helen WardDepartment of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-8238-5036
Wendy S BarclayDepartment of Infectious Disease, Imperial College London, London, UK.
Graham S CookeDepartment of Infectious Disease, Imperial College London, London, UK.ORCID https://orcid.org/0000-0001-6475-5056
Imperial College Healthcare NHS Trust · GBImperial College London · GBChelsea and Westminster Hospital NHS Foundation Trust · GBLondon School of Economics and Political Science · GB

Funding

British Heart Foundation RE/18/4/34215Medical Research Council MC_PC_19012Medical Research Council MR/J008761/1Medical Research Council MR/L01341X/1Medical Research Council MR/R015600/1Medical Research Council MR/S019669/1Wellcome Trust 200861/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntibodiesCovid-19Lateral flowLFIANeutralisationSARS-CoV-2Seroprevalence

Identifiers

PMID35673545
PMCPMC9152464
OpenAlexW4200043682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.